When starting method development for potency testing, it’s important to choose the right column dimension for the target analysis. In this work, different column dimensions of the Raptor ARC-18 phase were utilized to develop methods to meet various labs’ needs using HPLC-UV. To demonstrate the powerful resolving capabilities of Raptor ARC-18, a 50 x 3 mm, 2.7 µm column was used to analyze 7 cannabinoids, including CBD; CBDA;delta-9-THC; delta-8-THC; (6aR, 9S)-delta-10-THC; (6aR, 9R)-delta-10-THC; and THCA. Next, additional cannabinoids including CBDV, THCV, CBG, CBN, CBGA, and CBC were added to the previous analytes for a total of 13 cannabinoids. Using the same column dimension and mobile phases, a method was developed to resolve all analytes in 10 minutes. Finally, to include exo-THC and CBNA, a 150 x 3 mm, 2.7 µm column dimension was used to demonstrate the utility of a longer column dimension. Each of these methods was applied to hemp matrix to demonstrate the applicability of these methods in real-world samples.
Cannabis Potency Testing: Which Column Dimension is Right for You?
22 Jan 2026
Authors
-
View all postsJamie York is a principal scientist in the Applications Lab at Restek Corporation. She leads the development of innovative analytical methods tailored to the food, clinical, environmental, and cannabis markets. Jamie earned her PhD in chemistry from The University of Texas at Arlington, where she gained extensive expertise in a range of analytical techniques, including gas chromatography–vacuum ultraviolet (GC–VUV); gas chromatography–mass spectrometry (GC–MS); matrix-assisted laser desorption/ionization (MALDI); and liquid chromatography– mass spectrometry (LC–MS/MS); with a research emphasis on food and environmental analysis. Today, her work focuses on complex method development and advanced sample preparation strategies to support the evolving needs of the scientific community.
-
-

